Goldman Sachs Upgrades Agios Pharma (AGIO) to Neutral
Tweet Send to a Friend
(Updated - November 17, 2022 3:46 AM EST)
Goldman Sachs analyst Salveen Richter upgraded Agios Pharma (NASDAQ: AGIO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Salveen Richter upgraded Agios Pharma (NASDAQ: AGIO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
